Read more about:

Repair Biotechnologies

about repair biotechnologies

Repair Biotechnologies develops the Cholesterol Degrading Platform (CDP), allowing cells to safely break down a toxic excess of cholesterol, and thereby reverse the pathology of cholesterol- based conditions such as atherosclerosis and Non- alcoholic. The first (cardiovascular disease, 16%) and second (stroke, 11%) top causes of human mortality both result from atherosclerosis. The CDP has proven very successful in mice trials and the company is moving forward to human clinical trials in 2023.

Contact us

Let's Get Rejuvenated!

We’re happy to answer any questions you may have and help you determine your best practices to learn and invest in rejuvenation.

For more information about:
Schedule a Consultation

Start your journey to rejuvenation

Quick Links